BRAF and fleck corneal dystrophy: Oncogenic BRAF lesions (i.e., gene fusions and the recurrent Val600Glu amino acid substitution) have also been reported in low grade epilepsy-associated tumors (LEAT) and in FCD [29,30,31,32].